Workflow
和铂医药-B(02142.HK)10月13日耗资334万港元回购25万股

Core Viewpoint - Heptagon Pharmaceuticals-B (02142.HK) announced a share buyback of 250,000 shares at a cost of HKD 3.34 million on October 13 [1] Group 1 - The company executed a buyback program, indicating confidence in its stock value [1] - The total expenditure for the buyback was HKD 3.34 million [1] - The number of shares repurchased was 250,000 [1]